Mechanisms, pathophysiology, and therapy of arterial stiffness - PubMed
Review
Mechanisms, pathophysiology, and therapy of arterial stiffness
Susan J Zieman et al. Arterioscler Thromb Vasc Biol. 2005 May.
Abstract
Arterial stiffness is a growing epidemic associated with increased risk of cardiovascular events, dementia, and death. Decreased compliance of the central vasculature alters arterial pressure and flow dynamics and impacts cardiac performance and coronary perfusion. This article reviews the structural, cellular, and genetic contributors to arterial stiffness, including the roles of the scaffolding proteins, extracellular matrix, inflammatory molecules, endothelial cell function, and reactive oxidant species. Additional influences of atherosclerosis, glucose regulation, chronic renal disease, salt, and changes in neurohormonal regulation are discussed. A review of the hemodynamic impact of arterial stiffness follows. A number of lifestyle changes and therapies that reduce arterial stiffness are presented, including weight loss, exercise, salt reduction, alcohol consumption, and neuroendocrine-directed therapies, such as those targeting the renin-angiotensin aldosterone system, natriuretic peptides, insulin modulators, as well as novel therapies that target advanced glycation end products.
Similar articles
-
Arterial stiffness, endothelial function and novel pharmacological approaches.
Wilkinson IB, McEniery CM. Wilkinson IB, et al. Clin Exp Pharmacol Physiol. 2004 Nov;31(11):795-9. doi: 10.1111/j.1440-1681.2004.04074.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15566396 Review.
-
Agarwal R. Agarwal R. Curr Opin Nephrol Hypertens. 2007 Sep;16(5):409-15. doi: 10.1097/MNH.0b013e3282063b86. Curr Opin Nephrol Hypertens. 2007. PMID: 17693754 Review.
-
Pathophysiology, genetic, and therapy of arterial stiffness.
Cattan V, Kakou A, Louis H, Lacolley P. Cattan V, et al. Biomed Mater Eng. 2006;16(4 Suppl):S155-61. Biomed Mater Eng. 2006. PMID: 16823107 Review.
-
Hereditary and environmental influences on arterial function.
Hayward CS, Benetos A. Hayward CS, et al. Clin Exp Pharmacol Physiol. 2007 Jul;34(7):658-64. doi: 10.1111/j.1440-1681.2007.04656.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17581226 Review.
-
Wang X, Keith JC Jr, Struthers AD, Feuerstein GZ. Wang X, et al. Cardiovasc Ther. 2008 Fall;26(3):214-23. doi: 10.1111/j.1755-5922.2008.00051.x. Cardiovasc Ther. 2008. PMID: 18786091 Review.
Cited by
-
Noguchi KS, Moncion K, Wiley E, MacDonald MJ, Richardson J, Roig M, Tang A. Noguchi KS, et al. Front Physiol. 2021 May 17;12:666171. doi: 10.3389/fphys.2021.666171. eCollection 2021. Front Physiol. 2021. PMID: 34079473 Free PMC article.
-
Pflederer MC, Long CS, Beaty B, Havranek EP, Mehler PS, Keniston A, Krantz MJ. Pflederer MC, et al. Tex Heart Inst J. 2016 Apr 1;43(2):131-6. doi: 10.14503/THIJ-15-5053. eCollection 2016 Apr. Tex Heart Inst J. 2016. PMID: 27127427 Free PMC article.
-
Goetz WA, Yao J, Brener M, Puri R, Swaans M, Schopka S, Wiesner S, Creutzenberg M, Sievert H, Kassab GS. Goetz WA, et al. Bioengineering (Basel). 2024 Jun 12;11(6):603. doi: 10.3390/bioengineering11060603. Bioengineering (Basel). 2024. PMID: 38927839 Free PMC article.
-
Elastin aging and lipid oxidation products in human aorta.
Zarkovic K, Larroque-Cardoso P, Pucelle M, Salvayre R, Waeg G, Nègre-Salvayre A, Zarkovic N. Zarkovic K, et al. Redox Biol. 2015;4:109-17. doi: 10.1016/j.redox.2014.12.008. Epub 2014 Dec 18. Redox Biol. 2015. PMID: 25553420 Free PMC article.
-
Inversion of Left Ventricular Axial Shortening: In Silico Proof of Concept for Treatment of HFpEF.
Goetz WA, Yao J, Brener M, Puri R, Swaans M, Schopka S, Wiesner S, Creutzenberg M, Sievert H, Kassab GS. Goetz WA, et al. Bioengineering (Basel). 2024 Jul 2;11(7):676. doi: 10.3390/bioengineering11070676. Bioengineering (Basel). 2024. PMID: 39061758 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources